WHSI yields 2000000.00% · PFE yields 6.13%● Live data
📍 WHSI pulled ahead of the other in Year 1
Combined, WHSI + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of WHSI + PFE for your $10,000?
Wearable Health Solutions, Inc. provides personal response monitoring services and related products to subscribers with medical or age-related conditions in the United States. The company manufactures medical alarm devices that are used to summon help in the event of an emergency. It offers MediPendant, a medical alarm product with speaker in the pendant that enables the user to simply speak and listen directly through the pendant in the event of an emergency; and iHelp, a mobile medical alarm device that utilizes T-Mobile's 2G network to remotely locate a loved one and voice prompts, as well as a dealer portal that enables dealers to manage their own iHelp customer base. The company is also designing and developing iHelp+3G, a wearable biosensor device for health and wellness that operates on 3G network. It offers its products primarily for the elderly and physically disabled, as well as for persons living alone. The company markets its products through its Websites, medipendant.com, and ihelpalarm.com; and wholesalers, as well as distributes its products in Denmark, Ireland, Bermuda, and the People's Republic of China. The company was formerly known as Medical Alarm Concepts Holdings, Inc. and changed its name to Wearable Health Solutions, Inc. in June 2016. Wearable Health Solutions, Inc. was founded in 2008 and is based in Las Vegas, Nevada.
Full WHSI Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.